Philips to develop EMR for cardiology departmentPhilips Medical Systems has purchased CardioLogica, a cardiology information system developed by Cardiovascular Computer Systems, as part of a larger effort to develop an electronic medical record
Philips Medical Systems has purchased CardioLogica, a cardiology information system developed by Cardiovascular Computer Systems, as part of a larger effort to develop an electronic medical record product. CardioLogica is a specialized information system that brings together cardiac images and clinical and administrative data via a centralized software suite. It provides modules for patient scheduling, automated report generation and distribution, and other administrative functions. It also merges modality data into a single electronic folder and integrates images with reports, other records, and other information systems within the hospital. CardioLogica will be incorporated into Philips Inturis for Cardiology image and information management system.
In related news, Philips has signed a contract with Talk Technology to enhance Philips Inturis for Radiology PACS with voice recognition capabilities tailored to radiology applications.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.